Commercialization Reports. Throughout the Term and during the Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the sublicensees’ efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 3 contracts
Sources: Exclusive Patent License Agreement (Cellectis S.A.), Exclusive Patent License Agreement (GT Biopharma, Inc.), Exclusive Patent License Agreement (Cellectis S.A.)
Commercialization Reports. Throughout the Term and during the Post-Post- termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the sublicensees’ (or any further sublicensees’) efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 3 contracts
Sources: Exclusive Patent License Agreement, Exclusive Patent License Agreement (Calyxt, Inc.), Exclusive Patent License Agreement (Calyxt, Inc.)
Commercialization Reports. Throughout the Term and during the Post-termination PeriodTerm, and within thirty (30) days **** of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the sublicensees’ efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 2 contracts
Sources: Exclusive Patent License Agreement (REGENXBIO Inc.), Exclusive Patent License Agreement (REGENXBIO Inc.)
Commercialization Reports. Throughout the Term and during the Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the its sublicensees’ efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 1 contract
Sources: Confidentiality Agreement (Miromatrix Medical Inc.)
Commercialization Reports. Throughout the Term and during the Post-Post termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the sublicensees’ efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 1 contract
Sources: Exclusive Patent License Agreement
Commercialization Reports. Throughout the Term and during the Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s 's and the sublicensees’ ' efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Oxis International Inc)
Commercialization Reports. Throughout the Term and during the Post-termination Period, and within thirty (30) days of the date specified in the schedule set forth in section 10 of the EPLA, the Licensee shall deliver to the University written reports of the Licensee’s and the sublicenseesSublicensees’ efforts and plans to commercialize the Licensed Technology and to manufacture, offer to sell, or sell Licensed Products.
Appears in 1 contract
Sources: Exclusive Patent License Agreement (Arno Therapeutics, Inc)